The aim of this clinical and exploratory Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry is to establish high quality prevalence and incidence database for Cardiovascular-Kidney-Metabolic (CKM) syndrome, its major contributors, and the extent of the respective organ damaged.
At least 18 years of age
For stage 0: Individuals without overweight/obesity, metabolic risk factors (normoglycemia, normotension, normal lipid profile), Chronic kidney disease (CKD), or Cardiovascular disease (CVD)
Individuals with overweight/obesity or dysfunctional adipose tissue, without other metabolic risk factors or CKD
Individuals with metabolic risk factors (hypertriglyceridemia, arterial hypertension, metabolic syndrome, diabetes) or CKD
Individuals with CKM syndrome stage 4 according to the AHA
History of coronary artery disease, myocardial infarction, coronary artery intervention
History of atrial fibrillation
History of stroke
University Hospital, Basel, Switzerland
Lead sponsor